Company Comparison
Ginkgo Bioworks vs AI Therapeutics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Ginkgo Bioworks | AI Therapeutics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | — | San Diego |
| Founded | 2008 | — |
| Status | Active | Active |
| Last Funding Stage | — | Series A |
| Total Funding | $290M | $48M |
| Valuation | $4.2B | — |
What They Build
Ginkgo Bioworks
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly.
AI Therapeutics
A San Diego biotech company using AI to accelerate drug discovery and development processes.
Key Investors
Ginkgo Bioworks
AI Therapeutics
No investors listed.
Sector Overlap
Both Ginkgo Bioworks and AI Therapeutics operate in Biotech.
Browse all Biotech companies →